RanBP9 at the intersection between cofilin and Aβ pathologies: rescue of neurodegenerative changes by RanBP9 reduction

by Woo, J A, Boggess, T, Uhlar, C, Wang, X, Khan, H, Cappos, G, Joly-Amado, A, De Narvaez, E, Majid, S, Minamide, L S, Bamburg, J R, Morgan, D, Weeber, E, Kang, D E
Published 2015

A randomised, phase II study of intetumumab, an anti-αv-integrin mAb, alone and with dacarbazine in stage IV melanoma

by O'Day, S, Pavlick, A, Loquai, C, Lawson, D, Gutzmer, R, Richards, J, Schadendorf, D, Thompson, J A, Gonzalez, R, Trefzer, U, Mohr, P, Ottensmeier, C, Chao, D, Zhong, B, de Boer, C J, Uhlar, C, Marshall, D, Gore, M E, Lang, Z, Hait, W, Ho, P
Published 2011